text stringlengths 15 247 |
|---|
Uterine cervix, colposcopic biopsy;
Invasive squamous cell carcinoma |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 2) |
Uterine cervix, punch biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3) |
Lung, biopsy;
Adenocarcinoma |
Lung, biopsy;
Adenocarcinoma |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Uterine cervix, colposcopic biopsy;
Invasive squamous cell carcinoma |
Lung, biopsy;
Adenocarcinoma |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 90% |
Uterine cervix, punch biopsy;
Invasive squamous cell carcinoma |
Colon, colonoscopic biopsy;
Signet-ring cell carcinoma |
Colon, colonoscopic biopsy;
Adenocarcinoma, well differentiated |
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1) |
Colon, colonoscopic biopsy;
Mucinous carcinoma |
Rectum, colonoscopic biopsy;
Neuroendocrine tumor, G1 |
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 2)
with glandular involvement |
Lung, biopsy;
Adenocarcinoma |
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 5% |
Colon, colonoscopic biopsy;
Adenocarcinoma, poorly differentiated |
Colon, colonoscopic biopsy;
Adenocarcinoma, well differentiated with mucinous component |
Lung, biopsy;
Small cell carcinoma |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Colon, colonoscopic biopsy;
Mucinous carcinoma |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 80% |
Uterine cervix, colposcopic biopsy;
Endocervical adenocarcinoma in situ (AIS), HPV-associated |
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3) |
Lung, biopsy;
Adenocarcinoma |
Lung, biopsy;
No evidence of malignancy or granuloma |
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3) |
Uterine cervix, punch biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3) |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 90%), tumor volume: 60% |
Uterine cervix, punch biopsy;
Invasive squamous cell carcinoma |
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 100% |
Colon, colonoscopic biopsy;
Adenocarcinoma, poorly differentiated |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 25% |
Rectum, colonoscopic biopsy;
Chronic nonspecific inflammation |
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1) |
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 70% |
Lung, biopsy;
No evidence of malignancy or granuloma |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Lung, biopsy;
Squamous cell carcinoma |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 70% |
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
with glandular involvement |
Lung, biopsy;
Non-small cell carcinoma, favor squamous cell carcinoma |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Lung, biopsy;
Squamous cell carcinoma |
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1) |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 40%), tumor volume: 90% |
Rectum, colonoscopic biopsy;
Chronic nonspecific inflammation |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 10%), tumor volume: 60% |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Lung, biopsy;
Squamous cell carcinoma |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Uterine cervix, punch biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1) |
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1) |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 80%), tumor volume: 40% |
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1) |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 100% |
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1) |
Lung, biopsy;
Chronic granulomatous inflammation with necrosis |
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Uterine cervix, colposcopic biopsy;
Chronic nonspecific cervicitis with squamous metaplasia |
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
with glandular involvement |
Uterine cervix, colposcopic biopsy;
Chronic nonspecific cervicitis |
Urinary bladder, transurethral resection;
1. No tumor present
2. Chronic granulomatous inflammation with foreign body reaction
Note) The specimen includes muscle proper. |
Urinary bladder, transurethral resection;
Invasive urothelial carcinoma,
with involvement of muscle proper
Note) The specimen includes muscle proper. |
Urinary bladder, transurethral resection;
Non-invasive papillary urothelial carcinoma, low grade
Note) The specimen includes muscle proper. |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 5% |
Urinary bladder, transurethral resection;
Invasive urothelial carcinoma,
with involvement of subepithelial connective tissue
Note) The specimen includes muscle proper. |
Urinary bladder, transurethral resection;
Non-invasive papillary urothelial carcinoma, high grade
Note) The specimen includes muscle proper. |
Urinary bladder, transurethral resection;
1. Invasive urothelial carcinoma,
with involvement of subepithelial connective tissue
2. Urothelial carcinoma in situ
Note) The specimen does not include muscle proper. |
Urinary bladder, transurethral resection;
Invasive urothelial carcinoma,
with involvement of muscle proper
Note) The specimen includes muscle proper. |
Urinary bladder, transurethral resection;
Non-invasive papillary urothelial carcinoma, high grade
Note) The specimen includes muscle proper. |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 10% |
Urinary bladder, transurethral resection;
Invasive urothelial carcinoma,
with involvement of subepithelial connective tissue
Note) The specimen does not include muscle proper. |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 9 (5+4), grade group 5, tumor volume: 100% |
Prostate, biopsy;
No tumor present |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 30%), tumor volume: 90% |
Urinary bladder, transurethral resection;
Non-invasive papillary urothelial carcinoma, low grade
Note) The specimen includes muscle proper. |
Urinary bladder, transurethral resection;
Non-invasive papillary urothelial carcinoma, low grade
Note) The specimen includes muscle proper. |
Urinary bladder, transurethral resection;
Invasive urothelial carcinoma,
with involvement of subepithelial connective tissue
Note) The specimen includes muscle proper. |
Urinary bladder, transurethral resection;
Non-invasive papillary urothelial carcinoma, high grade
Note) The specimen includes muscle proper. |
Prostate, biopsy;
No tumor present |
Lung, biopsy;
Chronic granulomatous inflammation with necrosis |
Urinary bladder, transurethral resection;
1. Invasive urothelial carcinoma,
with involvement of subepithelial connective tissue
2. Urothelial carcinoma in situ
Note) The specimen includes muscle proper. |
Lung, biopsy;
Small cell carcinoma |
Prostate, biopsy;
No tumor present |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.